Advertisement
Advertisement
Trending on Psychiatric Times
1
Neurosterix Announces Phase 1 Study of NTX-253 for Schizophrenia
2
Zervimesine May Slow Progression of Dementia With Lewy Bodies, Phase 2 Results Show
3
The Times They Are a-Changin’
4
The Contest of the Confluence of Hanukkah and the Solstice: An Epilogue With Clinical Implications
5